DFM Platform

Cristanini S.p.A.: European Manufacturer of CBRN Decontamination Systems

Strategic-Technological Profile of an Italian Defence Company Contributing to CBRN Resilience, NATO Interoperability, and European Strategic Autonomy

18 pages · PDF · 03 February 2026 · Licensed single-user copy, watermarked to the buyer

Tactical Biotechnology, Human Enhancement & MedTech Italy

Cover of the DFM report “Cristanini S.p.A.: European Manufacturer of CBRN Decontamination Systems” — Defence-Finance Analysis, 18-page PDF

€299 excl. VAT — EU VAT calculated at checkout (VAT ID accepted for reverse charge); invoice issued after payment

One click to Stripe — guest checkout, no account. Your download appears on the confirmation page and arrives by e-mail right after payment (link valid 72 hours, up to 5 downloads).

About this report

Cristanini S.p.A. is an Italian defense-focused manufacturer specializing in chemical, biological, radiological and nuclear (CBRN) decontamination equipment. Founded in 1972 and headquartered in Rivoli Veronese, Verona, Italy , Cristanini has built a global reputation as a “Made in Italy” innovator in defense and civil protection.

Its product line includes advanced high-pressure water-jet and vacuum decontamination systems (e.g. the patented Sanijet and SX34 series) and mobile CBRN laboratories. The firm’s solutions are used for cleaning personnel, vehicles, infrastructure and sensitive equipment after CBRN exposure.

Key questions this report answers

Inside this report

Who it's for

Investors screening Cristanini S.p.A., competitors and partners assessing their position, and analysts who need a sourced, structured account of the entity and its technology.

Related reports

Methodology, format & delivery

DFM reports are built from primary and official sources — TED procurement notices, CORDIS and the EU Funding & Tenders Portal, EIB operations, the NATO Innovation Fund portfolio, SIPRI data, official budget documents and company disclosures — read together with the underlying legal texts. Sources are cited in the document; it reflects them as of its publication date (03 February 2026). You receive a 18-page PDF, watermarked to you on every page, delivered on the confirmation page and by e-mail immediately after checkout (personal link valid 72 hours, up to 5 downloads). Guest checkout, single-user licence — Terms of Sale.

Related on DFM

More Tactical reports · Biotechnology, Human Enhancement & MedTech · All reports

Prefer unlimited access?

Prefer unlimited access? Every report like this is included in the DFM Analysis subscription. See plans →

Get the full report — €299 →